NGS Adoption For Viral Safety: From Experimental Tool To Regulatory-Endorsed Standard

Once viewed as an exploratory tool, NGS is now emerging as a robust, regulatory-endorsed method for ensuring viral safety in biological medicinal products.

In this webinar, Donna McMutrie, Head of Strategy, Large Molecules, and Arnoud Boot, Senior Product Developer, will discuss how advances in validation, data interpretation, and regulatory guidance are accelerating NGS adoption in quality and safety testing.

What you will learn:

• Key drivers accelerating regulatory acceptance and standardization
• Case studies and lessons learned from early adopters
• Strategic implications for manufacturers of biologics and advanced therapies